|Endosomal trafficking of the receptor tyrosine kinase MuSK proceeds via clathrin-dependent pathways, Arf6 and actin.|
|Jump to Full Text|
|PMID: 23621612 Owner: NLM Status: MEDLINE|
|Muscle-specific kinase (MuSK), a receptor tyrosine kinase, is the key player during the formation of the neuromuscular junction. Signal transduction events downstream of MuSK activation induce both pre- and postsynaptic differentiation, which, most prominently, includes the clustering of acetylcholine receptors at synaptic sites. More recently, regulated MuSK endocytosis and degradation have been implicated as crucial events for MuSK signalling activity, implicating a cross-talk between signalling and endocytosis. In the present study, we use a live imaging approach to study MuSK endocytosis. We find that MuSK is internalized via a clathrin-, dynamin-dependent pathway. MuSK is transported to Rab7-positive endosomes for degradation and recycled via Rab4- and Rab11-positive vesicles. MuSK activation by Dok7 mildly affects the localization of MuSK on the cell surface but has no effect on the rate of MuSK internalization. Interestingly, MuSK colocalizes with actin and Arf6 at the cell surface and during endosomal trafficking. Disruption of the actin cytoskeleton or the proper function of Arf6 concentrates MuSK in cell protrusions. Moreover, inhibition of Arf6 or cytoskeletal rearrangements impairs acetylcholine receptor clustering and phosphorylation. These results suggest that MuSK uses both classical and nonclassical endosomal pathways that involve a variety of different components of the endosomal machinery.|
|Susan Luiskandl; Barbara Woller; Marlies Schlauf; Johannes A Schmid; Ruth Herbst|
|Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2013-05-23|
|Title: The FEBS journal Volume: 280 ISSN: 1742-4658 ISO Abbreviation: FEBS J. Publication Date: 2013 Jul|
|Created Date: 2013-07-05 Completed Date: 2013-09-11 Revised Date: 2013-11-05|
Medline Journal Info:
|Nlm Unique ID: 101229646 Medline TA: FEBS J Country: England|
|Languages: eng Pagination: 3281-97 Citation Subset: IM|
|© 2013 The Authors. FEBS Journal published by John Wiley & Sons Ltd on behalf of FEBS.|
|Center for Brain Research, Medical University of Vienna, Vienna, Austria.|
|APA/MLA Format Download EndNote Download BibTex|
Actins / metabolism*
Agrin / metabolism
Clathrin / metabolism*
Cytoskeleton / metabolism
Dynamins / metabolism
Endosomes / enzymology
Muscle Proteins / metabolism
Receptor Protein-Tyrosine Kinases / metabolism*
Receptors, Cholinergic / metabolism
rab GTP-Binding Proteins / metabolism
rab4 GTP-Binding Proteins / metabolism
|0/Actins; 0/Agrin; 0/Clathrin; 0/Dok-7 protein, mouse; 0/Muscle Proteins; 0/Receptors, Cholinergic; 152989-05-4/rab7 protein; EC 22.214.171.124/MuSK protein, mouse; EC 126.96.36.199/Receptor Protein-Tyrosine Kinases; EC 3.6.1.-/rab GTP-Binding Proteins; EC 3.6.1.-/rab11 protein; EC 188.8.131.52/ADP-Ribosylation Factors; EC 184.108.40.206/ADP-ribosylation factor 6; EC 220.127.116.11/rab4 GTP-Binding Proteins; EC 18.104.22.168/Dynamins|
Journal ID (nlm-ta): FEBS J
Journal ID (iso-abbrev): FEBS J
Journal ID (publisher-id): febs
Publisher: Blackwell Publishing Ltd
Copyright © 2013 Federation of European Biochemical Societies
Received Day: 23 Month: 12 Year: 2012
Revision Received Day: 12 Month: 4 Year: 2013
Accepted Day: 19 Month: 4 Year: 2013
Print publication date: Month: 7 Year: 2013
Electronic publication date: Day: 23 Month: 5 Year: 2013
Volume: 280 Issue: 14
First Page: 3281 Last Page: 3297
PubMed Id: 23621612
|Endosomal trafficking of the receptor tyrosine kinase MuSK proceeds via clathrin-dependent pathways, Arf6 and actin|
|Johannes A Schmid3|
1Center for Brain Research, Medical University of ViennaAustria
2Institute of Immunology, Medical University of ViennaAustria
3Center for Physiology and Pharmacology Department of Vascular Biology, Medical University of ViennaAustria
|Correspondence: Correspondence R. Herbst, Center for Brain Research, Medical University of Vienna, Spitalgasse 4, 1090 Vienna, Austria, Fax: +43 1 40160 934053, Tel: +43 1 40160 34350, E-mail: firstname.lastname@example.org
A neuromuscular junction (NMJ) forms as a result of intercellular interactions between a motor neurone, a muscle fibre and a Schwann cell. Signals from the nerve induce postsynaptic differentiation of the muscle membrane and, in turn, signals from the muscle induce presynaptic nerve terminal differentiation 1, 2.
The muscle specific receptor tyrosine kinase (RTK) MuSK is a key player during NMJ formation. MuSK is essential for NMJ formation because newborn mice lacking MuSK do not move or breathe and, consequently, die shortly after birth 3. Levels of acetylcholine receptor (AChR) expression are normal, although AChR clusters or other postsynaptic specializations are missing. In addition, motor axons fail to stop in MuSK mutant mice. Axons continue to grow and fail to form arborized nerve terminals. MuSK is activated by the large extracellular matrix protein agrin, which is synthesized by motor neurones, transported in motor axons, released from nerve terminals and deposited in the synaptic basal lamina 4–7. Similar to MuSK−/− mice, mice lacking agrin fail to form NMJs and die at birth as a result of respiratory failure 8. Agrin does not bind MuSK directly but interacts with Lrp4, a member of the low-density lipoprotein receptor family 9, 10. Lrp4 binds MuSK and the interaction of Lrp4 with agrin activates MuSK via an unknown mechanism. Lrp4 mutant mice also lack all forms of pre-and postsynaptic specializations 11. Taken together, agrin, Lrp4 and MuSK are the key players for NMJ formation and represent the primary scaffold at the developing NMJ that initiates both postsynaptic and presynaptic differentiation.
Current models suggest that MuSK is one of the first proteins present at the site of innervation, providing a primary scaffold for AChR clustering and NMJ formation 12. A signalling cascade requiring MuSK kinase activity and at least one additional tyrosine kinase has been implicated in AChR clustering 13–15. More recently, it was proposed that MuSK endocytosis is required for MuSK signalling 16. Zhu et al. 16 showed that agrin induced rapid internalization of MuSK. The expression of dominant-negative dynamin reduced agrin-stimulated MuSK internalization and AChR clustering. These results conform with previous studies of other RTKs, where ligand-induced internalization has been related to signalling events. Retrograde signalling mediated by the neurotrophin receptor TrkA currently represents the best system, supporting the idea that specific signals are generated by endosomes. It was reported that cell surface TrkA promotes nerve growth factor-induced survival, whereas internalized receptors are more active in the promotion of differentiation 17. Similarly, ligand-mediated endocytosis of the epidermal growth factor (EGF) receptor was shown to be required for EGF-induced signalling 18, 19. Current hypotheses propose that membrane trafficking controls signal transduction in one of two ways: (a) it controls the magnitude of the response or (b) it controls the specificity of the response.
In the present study, we aimed to examine the molecular mechanisms involved in MuSK endocytosis and its role during MuSK-dependent AChR clustering. Using an approach that specifically labels MuSK surface receptors, we showed that ligand-independent MuSK internalization preferentially occurs via a clathrin-dependent pathway. Dok7-dependent activation of MuSK does not alter the rate of internalization but favours a localization of MuSK in caveolin-specific structures. We observed a colocalization of MuSK with the small GTPase Arf6 on the cell surface and during endocytosis. Inhibition of the action of Arf6 leads to an accumulation of MuSK in cell protrusions and interferes with agrin-induced AChR clustering, supporting the notion that Arf6 plays an important role during MuSK endocytosis and function.
To study MuSK endocytosis, we decided to use an approach where we could specifically label surface receptors and follow their route of internalization by fluorescence microscopy 20. Accordingly, we inserted a streptavidin-binding sequence (SBP), called SBP-Tag, into the extracellular domain of MuSK. The SBP-MuSK construct was expressed in MuSK−/− muscle cells to confirm its ability to induce downstream signalling. Figure S1A,B shows that agrin-treatment induced MuSK activation and, consequently, AChR phosphorylation and clustering. To perform an initial dissection of the MuSK endocytosis pathway, we used a simple heterologous system (i.e. COS-7 cells). SBP-MuSK was expressed in COS-7 cells and surface receptors were labelled at 4 °C with DyLight 649-conjugated streptavidin. Cells were incubated for different time periods at 37 °C, at which temperature endocytosis occurs. Newly-synthesized MuSK was stained with DyLight 488-conjugated streptavidin and the labelled receptors were subsequently imaged. As shown in Fig. 1A, labelled SBP-MuSK was restricted to the cell surface without incubation at 37 °C. Increasing incubation periods at 37 °C lead to an accumulation of MuSK in vesicular structures, especially in the perinuclear region, resulting in a pronounced decrease in labelled surface MuSK (Figs 1A and S1C). To quantify MuSK endocytosis over time, we labelled surface MuSK and endocytosis was allowed to proceed at 37 °C for different time periods. Subsequently, streptavidin was stripped off the remaining MuSK surface molecules and intracellular SBP-MuSK was quantified by fluorescence-activated cell sorting (FACS). Figure 1B shows that 40% of surface MuSK was internalized within 5 min and that internalization continuously increased for the first 60 min, reaching a plateau at that time point. To validate that COS-7 cells are suitable for studying MuSK endocytosis, we performed biotinylation experiments to determine MuSK turnover. We found that MuSK turnover is similar in COS-7 cells transiently expressing MuSK compared to C2 muscle cells expressing endogenous MuSK (Fig. S1D,E).
RTK endocytosis is regulated by ligand-induced activation, which usually leads to increased internalization and sorting into specific endosomal pathways 21. Because MuSK cannot be activated by agrin in non-muscle cells 7, we used dominant-negative and constitutive-active mutants of MuSK to determine the effect of MuSK activation on MuSK internalization. Unexpectedly, the activation status of MuSK did not affect the rate of internalization in COS-7 cells (Fig. S1F,G). This observation was supported by biotinylation experiments, which revealed a similar turnover of MuSK wild-type and kinase mutants (Fig. S1D). These results demonstrate that MuSK endocytosis can be studied in living COS-7 cells and that turnover and internalization is similar to that in muscle cells and independent of its activation status.
A classical pathway of endocytosis occurs via clathrin-coated pits. This endocytic pathway is responsible for the internalization of nutrients, pathogens, growth factors and receptors 22. In particular, ligand-stimulated endocytosis of RTKs is often dependent on clathrin. To test whether MuSK endocytosis occurs via clathrin-coated pits, we determined the colocalization between SBP-MuSK and classical markers of the clathrin-dependent pathway, such as clathrin and transferrin receptor (Figs 2A and S2A). SBP-MuSK was labelled and internalization was imaged after 5 min. We observed a distinct colocalization of MuSK with these marker proteins. To extend these studies, we performed similar experiments with marker proteins of the nonclassical, clathrin-independent, lipid raft-dependent route, such as caveolin, cholera toxin B and CD59 (Figs 2A and S2A). We detected a similar colocalization of MuSK using these markers. A quantification using a threshold-and object-based colocalization analysis (as described in the Materials and methods) revealed a strong colocalization of MuSK with clathrin and a weaker colocalization with caveolin at the cell surface. Upon internalization, the colocalization between MuSK and clathrin is reduced but remains unchanged for MuSK and caveolin (Fig. 2B). A similar colocalization is observed between MuSK and the clathrin-specific marker transferrin. We further analyzed and quantified MuSK endocytosis by confocal microscopy, as well as by FACS as described above. Accordingly, we co-expressed SBP-MuSK with dominant-negative constructs or treated SBP-MuSK expressing cells with inhibitory compounds (Fig. 2C,D). Transferrin was used as a positive control (Fig. S2B). The expression of the carboxy-terminal domain of AP180 (AP180C), which inhibits clathrin-dependent endocytosis by sequestering clathrin, greatly reduced MuSK endocytosis. Similar effects were observed when expressing dominant-negative Eps15 (Eps15DIII), which is an adaptor protein involved in the regulation of clathrin-dependent endocytosis (Fig. 2D). The large GTPase dynamin 2 is an important regulatory protein within different endocytic pathways. We either treated SBP-MuSK expressing cells with the inhibitor dynasore, which inhibits specifically the GTPase activity of dynamin, or co-expressed the dominant-negative dynamin 2 mutant Dyn2K44A and SBP-MuSK. Blocking the function of dynamin impaired MuSK endocytosis to a similar degree as blocking clathrin. Taken together, MuSK is predominantly internalized via pathways that involve clathrin and dynamin. At the cell surface, MuSK preferentially colocalizes with clathrin, which appears to deliver MuSK rapidly into intracellular compartments.
To analyze the endosomal routing of MuSK, we co-expressed SBP-MuSK and different endosomal marker proteins (Fig. 3). We found a rather low colocalization of MuSK and Rab5 during early endocytosis (after 5 min), as well as at later time points (after 15 min), with a colocalization in the range of 6–9% (Fig. 3A). A similar localization pattern was observed for MuSK and the early endosomal marker EEA1 (data not shown), indicating that MuSK is not transported via classical endosomes or just partially localized to these compartments. However, we found a much higher colocalization of MuSK with the late endosomal marker Rab7, indicating that it is transported via Rab7-positive endosomes to lysosomes similar to other surface receptors (Fig. 3A). Surface molecules are often recycled via Rab4-and/or Rab11-positive endosomes. In support of MuSK recycling, we found that MuSK colocalized with Rab4 or Rab11 (Fig. 3B). To sustain these findings, we expressed MuSK with an extracellular haemagglutinin (HA)-Tag in COS-7 cells. Surface MuSK was labelled by antibody feeding in living cells and endocytosis was allowed to proceed upon transfer to 37 °C. After 30 min, the remaining surface antibody-labelled MuSK was stripped and cells were put back at 37 °C. Recycled MuSK was detected by staining fixed cells with a fluorescently-labelled secondary antibody against the bound HA antibody. As shown in Fig. 3C, after 15 and 30 min, recycled MuSK was detected on the plasma membrane. Recently, it was reported that MuSK recruitment to Rab11-positive endosomes initiates a signalling cascade important for AChR pre-patterning in zebrafish 23. Disruption of the function of Rab11 interferes with MuSK trafficking to endosomes and subsequent MuSK signalling. We therefore tested whether similar effects on MuSK localization are observed in our system upon the expression of Rab11 wild-type or dominant-negative, GDP-locked Rab11 S25N (Figs. 3D and S3). The expression of Rab11 wild-type induced an accumulation of MuSK in the perinuclear region, where it colocalized with Rab11. In addition, MuSK puncta were increasingly observed in the periphery, indicating a recycling back to the cell surface. The expression of Rab11 S25N also recruited MuSK to the perinuclear region but failed to induce MuSK recycling. Taken together, these observations suggest that internalized MuSK is targeted for degradation in lysosomes via Rab7-positive endosomes and also travels along Rab4-/Rab11-positive endosomes back to the cell surface.
In the course of our experiments, we detected a high degree of colocalization between MuSK and actin at the cell surface and during endocytosis, with approximately 30% colocalization after 15 min (Figs 4A and S4A). In particular, we noted a tubular ruffle-like distribution pattern of MuSK and actin. Cytoskeletal rearrangements are crucial for a variety of different endocytic pathways and this is also reflected by characteristic endocytic membrane morphologies. Tubular and vesicular plasma membrane morphologies are found in Arf6-dependent endocytosis 21, 24. Therefore, we asked whether MuSK colocalizes with Arf6 to actin-positive structures. SBP-MuSK and Arf6-GFP or Arf6-HA were co-expressed in COS-7 cells and surface MuSK was labelled (Figs 4B and S4B). Colocalization of MuSK, Arf6 and actin was identified on the cell surface, as well as during MuSK endocytosis, with approximately 40% colocalization of MuSK and actin in the beginning, followed by a gradual decrease over time. MuSK/Arf6 showed 22% colocalization at the start of endocytosis, peaking after 15 min at 27%, followed by a subsequent decrease similar to MuSK/actin colocalization. MuSK was found in Arf6-positive structures after internalization, suggesting that Arf6 is involved in endocytosis rather than recycling. MuSK, Arf6 and actin were colocalized to ruffle-like structures, which did not accumulate perinuclearly. After 60 min of endocytosis, surface and intracellular MuSK was decreased. In the absence of exogenous Arf6, MuSK accumulated in the perinuclear region, whereas the co-expression of Arf6 routed MuSK into ruffles. Interestingly, blocking clathrin-dependent endocytosis by expressing AP180C induced a similar ruffle-like distribution of MuSK. Moreover, MuSK and Arf6 colocalized within these structures (Fig. S4C). Furthermore, we found a colocalization of MuSK, Arf6 and MHCI, which is transported by Arf6-dependent mechanisms (Fig. 4C). Next, we determined whether this colocalization between MuSK and Arf6 is specific by studying the distribution of MuSK relative to Arf1, another member of the Arf family, which has its function in the assembly of cytosolic coat proteins onto Golgi membranes. We found no colocalization between MuSK and Arf1 (Fig. S4D).
Arf6-dependent endocytosis relies on cytoskeletal rearrangements, on the conversion of phosphatidylinositol (4,5)-bisphosphate (PIP2) into phosphatidylinositol (3,4,5)-trisphosphate (PIP3), and also on Arf6 activity. Specific inhibitors and activators of these different events were used to study their role during MuSK internalization (Fig. 5). We used cytochalasin D to disturb the actin network and found that MuSK, Arf6 and actin accumulate in large aggregates close to the membrane. These accumulations occurred intracellularly because we did not find a decrease in MuSK internalization (Fig. S5A). When we inhibited Arf6 activation by competition with a synthetic myristoylated Arf6 N-terminal peptide, MuSK aggregated in membrane ruffles together with actin and Arf6 25–27. The conversion of PIP2 into PIP3 can be blocked using the phosphatidylinositide 3-kinase inhibitor wortmannin. Treatment of SBP-MuSK/Arf6 expressing cells with wortmannin interfered with MuSK internalization and led to an accumulation of MuSK in membranous actin-positive structures. The expression of wild-type Arf6 does not affect the rate of MuSK internalization (Fig. S5B). However, activating Arf6 with aluminum fluoride (AlF) or expressing constitutively active Arf6 Q67L disturbed MuSK internalization. Here, MuSK, Arf6 and actin aggregated in enlarged vacuolar membranes, which resulted from a blocked transport of internalized membranes and cargos to early endosomes. These observations correspond to studies showing that phosphatidylinositide 3-kinase inhibitors such as wortmannin block the transport of MHCI 28. Moreover, studies on Arf6-dependent protein trafficking have shown that the expression of Arf6 Q67L leads to an accumulation of cargo such as MHCI in enlarged positive vacuoles and inhibits their fusion with endosomes 28, 29. In addition, it was previously reported that the G protein activator AlF induces the translocation of over-expressed Arf6 to the cell membrane and stimulates the formation of actin-rich surface protrusions 30, 31. Therefore, the results obtained in the present study suggest that MuSK endocytosis is Arf6-dependent and involves cytoskeletal rearrangements.
MuSK is activated by agrin via Lrp4. Lrp4 binds to agrin and, at the same time, interacts with MuSK 9, 10. This presumably results in a structural rearrangement that leads to an autoactivation of MuSK. Furthermore, MuSK activation requires the binding of the cytoplasmic adaptor protein Dok7, which fosters MuSK dimerization and trans-autophosphorylation of the MuSK activation loops 32. This complicated mechanism of activation has made it difficult to study agrin-induced MuSK activation outside of muscle cells. To activate MuSK in COS-7 cells, we co-expressed MuSK and Dok7, which was previously shown to induce MuSK phosphorylation (Fig. S6A) 33. As shown in Fig. 6A,B, tyrosine phosphorylation was greatly increased in the presence of Dok7, as was the colocalization of MuSK and phosphotyrosine. Moreover, we observed a strong colocalization of MuSK and Dok7, as well as MuSK, Dok7 and the phosphotyrosine staining signal, at the cell surface and during subsequent endocytosis (Fig. 6C). Furthermore, we observed a colocalization of MuSK and Arf6, as well as Dok7, after 15 min of internalization (Fig. S6B). Similarly, MuSK, Arf6 and phosphotyrosine colocalized at the cell surface and during internalization (Fig. S6C). Although we detected a strong MuSK activation upon Dok7 expression, the internalization rate of MuSK was not altered (Fig. 7A). After 5 min of internalization, 40% of surface MuSK was detected intracellularly. This increased to approximately 70–80% after 15 and 30 min. To determine whether Dok7-dependent MuSK activation leads to a re-routing of MuSK into a specific endosomal pathway, we examined MuSK colocalization with clathrin and caveolin in the presence and absence of Dok7 (Fig. 7B). We found that surface MuSK localized increasingly towards caveolin-specific compartments in the presence of Dok7 and at the expense of MuSK/clathrin colocalization. Upon MuSK internalization, the MuSK/clathrin colocalization decreased, whereas MuSK/caveolin colocalization remained unchanged. A similar effect on the subcellular localization was observed for a kinase-active MuSK mutant (Fig. S6D). By contrast, Dok7-dependent MuSK activation did not alter the regulation of MuSK internalization (compare Figs 7C and 1B). Interestingly, we found a slightly increased internalization when we co-expressed MuSK and Lrp4, which was also shown to foster MuSK autoactivation 9, 10. Taken together, these results indicate that MuSK activation by Dok7 does not alter MuSK internalization but favours a localization of MuSK in caveolin-positive structures.
The expression of dominant-negative dynamin blocks agrin-induced MuSK endocytosis and agrin-induced AChR clustering 16. We treated agrin-stimulated C2 myotubes either with the cytoskeletal inhibitor cytochalasin D, the dynamin blocker dynasore, the myristoylated Arf6 peptide to block Arf6 activity, or AIF to activate Arf6, and assayed the resulting AChR clustering (Fig. 8A,B). Inhibition of cytoskeletal rearrangements with cytochalasin D reduced the size and number of AChR clusters by approximately 50% compared to untreated myotubes. Blocking dynamin-dependent endocytosis had a less pronounced effect on the AChR cluster size but reduced the cluster number similar to cytochalasin D. The addition of myristoylated Arf6 peptide had no effect on cluster length but decreased the number of clusters per myotube. By contrast, a myristoylated Arf1 peptide did not affect AChR cluster length or number (Fig. S7). Most severely, the GTPase activating agent AlF, which interferes with membrane fusion during endocytosis via the action of Arf6, almost completely abolished agrin-induced AChR clustering and reduced the length of remaining clusters. In addition, AlF treatment also reduced AChR phosphorylation by approximately 50% (Fig. 8C). These results conform with previous findings implicating the cytoskeleton and dynamin during AChR clustering and now also add Arf6 as an additional regulatory factor.
Activation of MuSK and downstream signalling is a crucial event during AChR clustering at the NMJ. It was recently shown that the regulated removal of surface MuSK by endocytosis influences AChR clustering, implicating a cross-talk between signalling and endocytosis 16. To learn more about the mechanisms of MuSK endocytosis, we have developed an in vivo imaging approach to follow MuSK internalization and endocytosis. We demonstrate, in COS-7 cells, that MuSK internalization occurs predominantly via a clathrin-and dynamin-dependent pathway. MuSK accumulates perinuclear in Rab7-positive late endosomes and is also found in Rab4-and Rab11-positive recycling endosomes. Co-expression of MuSK and Dok7 induces MuSK phosphorylation but subsequent endocytosis is not increased. MuSK colocalizes with actin and the small GTPase Arf6 at the cell surface and during endocytosis. Impairment of Arf6-dependent endocytosis using different treatments leads to an accumulation of MuSK in protrusions and interferes with agrin-induced AChR clustering.
Clathrin-mediated endocytosis (CME) has been considered as the predominant mechanism by which endocytosis of RTKs occurs. More recently, it was demonstrated that ligand-activated RTKs are trapped into lipid rafts and that they are endocytosed via caveolae 22. However, advances in the field have also revealed that additional endocytic pathways exist, although little is known about their exact contribution and importance. Using different treatments to block CME endocytosis, we found that MuSK is predominantly internalized by a clathrin-dependent pathway. Only approximately 30% of MuSK internalizes independent of clathrin. Interestingly, we found that, after increased periods of endocytosis, the internalization of MuSK recovered to approximately 80% in the presence of inhibitory agents (data not shown). This implies that MuSK is able to find alternative routes of entry by switching to different endosomal pathways. Internalization via multiple pathways has been reported for several molecules, such as for the EGF receptor or the TGFβ receptor 22,34–36. It remains unclear which other alternative pathways are used. One of these clathrin-independent endocytosis (CIE) pathways might, in accordance with our observations, include actin and Arf6.
MuSK is colocalized with Arf6 at the plasma membrane, as well as during subsequent endocytosis. Arf6 is a small GTPase that has been implicated as central regulator of CIE 37. This pathway has been studied using the cargo proteins MHCI and CD59 38. MHCI and CD59 both colocalize with Arf6 during early endocytosis and later during recycling 39. The CIE pathway is characterized by the specific lipid composition of the involved endocytic structures. Phosphatidylinositol 4-phosphate 5-kinase, which is activated by Arf6, produces PIP2, a critical component of early endocytic compartments 40. A loss of PIP2 from these structures is essential for further transport of membrane and cargo to downstream endosomes 41. For that, Arf6 has to be inactivated shortly after internalization. The expression of constitutively active Arf6 Q67L mutant leads to an accumulation of enlarged vacuolar membranes and blocks the progression of endocytosis. Consistent with these observations, the expression of the Arf6 Q67L mutant leads to an accumulation of MuSK in enlarged actin-rich vacuolar membranes. Similarly, other treatments that interfere with Arf6 action, such as wortmannin, which blocks the conversion of PIP2 into PIP3, or AlF, which activates force-expressed Arf6, have a similar effect. On the other hand, Arf6 has also been implicated in CME as a regulator of coated-pit assembly 42. Therefore, it also appears possible that Arf6 participates in the CME of MuSK. However, when we inhibit CME by the expression of AP180C, MuSK still colocalizes with Arf6 to ruffle-like structures, arguing against a role for Arf6 in the clathrin-dependent endocytosis of MuSK.
During early endocytosis, MuSK not only colocalizes predominantly with clathrin, but also to some degree with caveolin (approximately 20%). After 5 min of endocytosis, the colocalization of MuSK and caveolin remains unchanged, whereas the colocalization of MuSK and clathrin decreases. This can be explained by a trapping of MuSK in lipid rafts or by a slower internalization rate via caveolin-positive compartments. At later time points, MuSK is increasingly found in vesicles containing Rab5 and EEA1. These vesicles are located in the perinuclear region and might represent sorting endosomes or multivesicular bodies, which carry cargo destined for degradation. Accordingly, we noted a strong colocalization of MuSK and Rab7-positive endosomes during late endocytosis, implying that MuSK is degraded via lysosomes. On the other hand, MuSK is also recycled back to the plasma membrane. This transport appears to occur via Rab4-and Rab11-positive endosomes. Blocking Rab11 impairs MuSK recycling and concentrates MuSK in large perinuclear vesicles. This observation contradicts the findings observed in zebrafish, where the inactivation of Rab11 results in a diffuse cytoplasmic localization of MuSK protein. It has been postulated that Wnt11-induced MuSK endocytosis localizes MuSK to Rab11-positive recycling endosomes, thereby inducing a signalling cascade via planar cell polarity components 23. It is currently unclear whether MuSK activation by Wnt11 is Lrp4 dependent and what role Lrp4 plays during AChR pre-patterning. Recent data suggest that Wnt proteins require Lrp4 to activate MuSK 43. This might explain why Rab11 regulates MuSK localization differently in COS-7 cells compared to zebrafish embryos.
Similar to other RTKs, MuSK is phosphorylated upon activation, thereby initiating a downstream signalling cascade. However, the mode of activation differs considerably between MuSK and other RTKs, such as EGF receptor, Trk receptors or insulin receptor. First, MuSK is not activated by ligand-binding but rather by the ligand-induced interaction with the co-receptor Lrp4, which presumably results in a conformational rearrangement of MuSK 9, 10. Second, the intracellular adaptor protein Dok7 regulates MuSK activation by supporting MuSK dimerization via its dimeric arrangement, which is facilitated by the Dok7 PH domain 32, 33. It was previously reported that agrin treatment not only stimulates MuSK activation, but also MuSK endocytosis 16. In the present study, we show that MuSK endocytosis occurs independently of its activation status using kinase-inactive and active mutants. Although these results indicate that MuSK activation is not necessary for endocytosis and that a constitutive turnover of MuSK proteins exists, it is also possible that the use of MuSK mutant proteins does not appropriately reproduce agrin-induced MuSK activation. In another approach, we activated MuSK by co-expressing Dok7. Here, we observed a strong tyrosine phosphorylation of MuSK and a co-trafficking of Dok7 and MuSK during early endocytosis. However, the rate of MuSK endocytosis was not affected. On the other hand, Dok7 expression apparently resulted in a preferential association of MuSK with caveolin-specific structures. This is in line with observations showing that activated RTKs are accumulated in lipid rafts before internalization 44, 45. Because we could not detect any effect on the rate of MuSK internalization, it might be possible that Dok7-dependent MuSK activation is not sufficient to alter MuSK endocytosis to the same extent as stimulation with agrin would do (see below). Further studies are required to clarify these results.
It has previously been reported that MuSK endocytosis is induced by agrin-treatment and that this endocytosis depends on dynamin 2 16. We also find a reduction of MuSK endocytosis using either the dominant-negative mutant Dyn2K44A or the chemical blocker dynasore. However, this inhibition is not dependent on MuSK activation because we find the same degree of inhibition when MuSK has been activated by Dok7. This raises the possibility that activation of MuSK with agrin could potentiate the effect of dynamin on MuSK endocytosis. An indication that agrin-Lrp4 might play a role in MuSK endocytosis comes from our data demonstrating an accelerated internalization of MuSK in the presence of Lrp4. Taking the limitations of our model system into account, it will be important to extend our findings to muscle cells using a similar approach of in vivo imaging. Such studies will define the endosomal pathways used by MuSK and will help to understand the mechanisms that are involved in MuSK recycling and degradation.
GFP-tagged Arf6 (wt, Q67L) and HA-tagged Arf6 (wt) were kindly provided by Dr J. Donaldson (National Institutes of Health, Bethesda, MD, USA). GFP-tagged Arf1 was a gift from Dr J. Presley (Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada). GFP-tagged Dyn2a(K44A) and caveolin1 were a gift from Dr A. Helenius (ETH Zurich, Switzerland). GFP-tagged clathrin and Myc-tagged AP180C were a gift from Dr D. Blaas (Max Perutz Laboratories, Vienna, Austria) and GFP-tagged Actin was kindly provided by Dr V. Small (IMBA, Austrian Academy of Sciences, Vienna, Austria). GFP-tagged Eps15(DIII) was a gift from Dr A. Benmerah (Institute Cochin, Université Paris Descartes, Paris, France). GFP-tagged Rab7/Rab11/Rab4 and pLexA-Rab5 were a gift prom Dr M. Zerial (Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany). Rab11 S25N was provided by Dr M. Granato (University of Pennsylvania, Philadelphia, PA, USA). Rab5 was cloned into pEGFP-C2 (Clontech, Palo Alto, CA, USA) using EcoRI 46. SBP-MuSK (wt) was generated by introducing the SBP sequence into a 10 amino acid alternative insert in the extracellular domain of MuSK by PCR. pBabe/TK-Dok7-HA and pBabe/Lrp4 9 were a gift from Dr S. Burden (NYU School of Medicine, New York, NY, USA). HA-MuSK was generated by insertion of a HA-Tag at the N-terminus of MuSK after the signal sequence (Asn20). pGFP-TK/Dok7 was generated by insertion of a CMV/EGFP/SV40 cassette and a TK/Dok7/BGHpA fragment into Litmus 29 (New England Biolabs, Beverly, MA, USA). The control plasmid pGFP lacks the TK/Dok7/BGHpA cassette. PTS2-GFP 47 was kindly provided by Dr M. Kunze (Center for Brain Research, Medical University of Vienna, Austria).
Antibodies against the extracellular domain (Ig1–2) of MuSK were produced in rabbits (V. Diederichs and R. Herbst, unpublished data). Biotin-and Alexa 594-conjugated α-bungarotoxin (α-BGT) were obtained from Invitrogen (Carlsbad, CA, USA). Rhodamine-conjugated phalloidin, cytochalasin D, dynasore, genistein and wortmannin were purchased from Sigma-Aldrich (St Louis, MO, USA). DyLight 649-conjugated transferrin, Cy3-, DyLight 488-and DyLight 649-conjugated streptavidin were purchased from Jackson ImmunoResearch Laboratories (Ben Harbor, ME, USA). Myristoylated Arf6 N-terminal peptide (2–13) was obtained from Merck (Darmstadt, Germany). Anti-MHCI and anti-CD59 were kindly provided by Dr H. Lassmann (Center for Brain Research, Medical University of Vienna, Austria). Streptavidin agarose beads were obtained from Novagen. Antibodies purchased from commercial sources were: anti-AChR β (Sigma-Aldrich), anti-clathrin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-caveolin (Cell Signaling, Beverly, MA, USA), anti-HA (Sigma-Aldrich), anti-myc 9E10 (Sigma-Aldrich), anti-GFP (Santa Cruz Biotechnology), anti-phosphotyrosine PY-100 (Cell Signaling), anti-phosphotyrosine PY99 (Santa Cruz Biotechnology) and anti-actin (BD Transduction Laboratories, Lexington, KT, USA). Alexa 488-conjugated secondary antibodies were obtained from Invitrogen. Cy3-, DyLight 649-and Texas Red-conjugated secondary antibodies and goat anti-mouse/goat/rat/rabbit horseradish peroxidase-conjugated secondary antibodies were purchased from Jackson ImmunoResearch Laboratories. Soluble neural A4B8 agrin was prepared from HEK 293T as described previously 14.
COS-7 cells, obtained from ATCC (Wesel, Germany), were cultured in DMEM supplemented with glutamine, 4.5 mg·mL−1 glucose, 10% fetal bovine serum and 100 μg·mL−1 penicillin/streptomycin. C2 myoblasts were originally obtained from the laboratory of Dr S. Burden (NYU School of Medicine) and have been used in our laboratory since 2002. Cells were grown and differentiated as described previously 48. MuSK−/− muscle cells were generated in the laboratory of Dr S. Burden (NYU School of Medicine) and have been used in our laboratory since 2002 14. COS-7 cells were transfected with SBP-tagged MuSK using TurboFect (Fermentas, Glen Burnie, MD, USA). Briefly, cells were plated on coverslips overnight and transfected the next day with 1 μg of DNA and 2 μL of TurboFect in 1 mL of growth medium. Cells were used for experiments 20 h after transfection.
To study MuSK endocytosis, transfected cells were starved for 30 min in DMEM, stained with Cy3-, DyLight 649-or DyLight 488-conjugated streptavidin at 4 °C in staining buffer SB (140 mM NaCl, 20 mM Hepes, 1 mM CaCl2, 1 mM MgCl2 and 5 mM KCl, pH 7.4) containing 1% BSA, followed by incubation at 37 °C for different time points. Cells were fixed with 4% paraformaldehyde (PFA)/NaCl/Pi for 10 min at room temperature (RT), mounted in polyvinyl alcohol and visualized using a Leica TCS SP5 spectral confocal microscope with an HCX PL APO CS 63× 1.4 oil objective (Leica Microsystems, Wetzlar, Germany). For the disruption of the actin cytoskeleton, transfected cells were incubated at 37 °C in the presence of 1 μM cytochalasin D. For blocking dynamin function, cells were pre-incubated for 30 min with 80 μM dynasore. After staining at 4 °C, cells were incubated at 37 °C in the presence of dynasore. For disturbing the function of Arf6, cells were pre-treated with 5 μM myr-ARF6 or myr-ARF1 peptide (Merck Millipore, Billerica, MA, USA) for 2 h, with 10 μM wortmannin for 1 h or with AlF (30 mM NaF and 50 μM AlCl3) for 30 min. Controls were treated with the solvent dimethylsulfoxide. After staining at 4 °C, cells were incubated at 37 °C in the presence of the peptide, wortmannin or dimethylsulfoxide. To examine MuSK recycling, transfected cells were stained with anti-HA antibodies (dilution 1: 100) in staining buffer SB for 60 min at 4 °C, washed with cold NaCl/Pi and incubated with warm SB at 37 °C for 30 min. Cells were placed on ice, stripped with 50 mM glycine, 100 mM NaCl (pH 3.0), washed with cold NaCl/Pi and incubated with warm SB at 37 °C for different time periods. Subsequently, cells were rinsed with cold PBS, fixed with 1% PFA/NaCl/Pi and stained with Texas Red-conjugated anti-rabbit secondary antibody in SB containing 1% BSA/5% fetal bovine serum. When internalized MuSK was detected, cells were permeabilized with 0.1% Triton/NaCl/Pi before antibody staining. Stained cells were mounted in polyvinyl alcohol and visualized using a Leica TCS SP5 spectral confocal microscope with a HCX PL APO CS 63× 1.4 oil objective.
Fixed cells were permeabilized with 0.1% Triton/NaCl/Pi for 5 min at RT, incubated with blocking solution (NaCl/Pi containing 10% fetal bovine serum) followed by incubation with appropriate primary antibodies for 1 h at RT. After washing with NaCl/Pi, cells were incubated with fluorophore-conjugated secondary antibodies with or without rhodamine-labelled phalloidin.
COS-7 cells were plated on 12-well plates and transfected with SBP-MuSK and pEGFP (or the appropriate constructs as indicated in the figures) the next day using TurboFect. For Dok7-dependent MuSK activation, cells were transfected with SBP-MuSK and pGFP or pGFP-TK/Dok7. Twenty to 22 h after transfection, cells were starved for 60 min in DMEM. Dynasore (80 mM in dimethylsulfoxide) or dimethylsulfoxide were added at a 1: 1000 dilution during the last 30 min of starvation after washing the respective wells at least four times with DMEM to remove all remaining serum traces. Cells were then stained with DyLight 649-conjugated streptavidin at 4 °C in staining buffer SB (see above) and incubated for the indicated time periods at 37 °C to allow endocytosis. Any remaining surface staining was removed by two sequential washes with NaCl/Pi (pH 2.6) for 2 min each. Cells were harvested by incubation with trypsin for 15 min at 4 °C followed by resuspension in ice-cold FACS buffer (NaCl/Pi supplemented with 3% fetal bovine serum). Cells were sorted according to their MuSK (DyLight 649) and GFP signals using a BD FACSCalibur flow cytometer (Becton-Dickinson Biosciences, Franklin Lakes, NJ, USA). All experiments included at least duplicate samples and 50 000 cells per sample were counted. Internalized MuSK was calculated as the ratio of double-positive cells (GFP-positive and MuSK-positive) and total GFP-positive cells. The total MuSK signal (without stripping step) was used as a reference value to calculate the percentage uptake for each sample. To show the impact of the different endocytosis inhibitors, the uptake in the control sample (untreated or without dominant-negative construct) was set to 100%.
C2 myotubes were stimulated with agrin for 8 h and incubated with Alexa 594-conjugated α-BGT to label AChRs for 45 min. Cells were washed with NaCl/Pi, fixed with 4% PFA, mounted in polyvinyl alcohol and visualized using a Leica DM IRB fluorescence microscope with a 63×/1.4–0.60 oil objective. Cluster length and number was quantified using METAMORPH IMAGING software (Molecular Devices, Sunnyvale, CA, USA). To determine the effect of inhibitors on AChR cluster formation, myotubes were stimulated with agrin 4.8 in the presence or absence of inhibitors (cytochalasin D: 1 μM, dynasore: 80 μM, myr-Arf6: 50 μM). For AlF treatment, media was replaced after 4 h with new media containing agrin and fresh NaF and AlCl3.
Differentiated C2 cells were starved for 2 h in DMEM followed by incubation with or without AlF (30 mM NaF and 50 μM AlCl3) for 30 min. Old medium was removed and new DMEM was added together with fresh AlF and agrin. After 60 min of incubation, cells were lysed with RIPA buffer (1% NP-40, 150 mM NaCl, 50 mM Tris pH 7.5, 0.5% deoxycholate) followed by an AChR pull-down for 1 h with 2 ng·mL−1 biotinylated α-BGT followed by incubation with streptavidin agarose beads for 1 h and immunoblotting. The signal intensities were quantified on a FluorS MultiImager (Bio-Rad, Hercules, CA, USA) using Quantity One (Bio-Rad).
For each experimental condition, images of more than 10 cells from at least two independent experiments were acquired using a Leica TCS SP5 confocal microscope and were analyzed with IMAGEJ (NIH, Bethesda, MD, USA) using a self-generated macro (Doc. S1). In brief, two grey scale images to be analyzed for colocalization were subject to an automatic thresholding based on maximum entropy of the histogram (MaxEntropy threshold method in IMAGEJ), followed by area measurement of the thresholded objects (using the ‘Analyze Particles’ routine and a size limit of 5 pixels) for both images. The overlap of the two images was determined by a logical AND operation (using the image calculator routine) and the area of the resulting colocalization objects was again determined using thresholding and the ‘Analyze Particles’ command, as above. The area of these overlapping objects was related to the thresholded area of the relevant marker to calculate a percentage of colocalization. As negative control, we used MuSK/Arf1 colocalization, as well as the co-expression of MuSK and PTS2-GFP (GFP fused to the peroxisomal targeting signal type 2 generating a peroxisomal marker). Because peroxisomes and endosomes do not overlap but exhibit a similar localization pattern, they are perfectly suited to serve as negative control for the colocalization analysis. For all experiments, more than 10 cells were analyzed.
An independent sample Mann–Whitney U-test was performed using SPSS, version 18 (IBM, Armonk, NY, USA) to compare different inhibitory effects on MuSK endocytosis and signalling. *P < 0.05 was considered statistically significant. A double asterisk (**) indicates a significance lower than 0.01%.
We are grateful to Alexandre Benmerah, Dieter Blaas, Steve Burden, Julie Donaldson, Michael Granato, Ari Helenius, Markus Kunze, Hans Lassmann, John Presley, Vic Small and Marino Zerial for providing plasmids and antibodies. This study was supported by grants from the Austrian Science Fund (P19223 and P21667) to R.H.
|1.||Burden SJ. Building the vertebrate neuromuscular synapseJ NeurobiolYear: 200253501511|
|2.||Sanes JR,Lichtman JW. Induction, assembly, maturation and maintenance of a postsynaptic apparatusNat Rev NeurosciYear: 2001279180511715056|
|3.||DeChiara TM,Bowen DC,Valenzuela DM,Simmons MV,Poueymirou WT,Thomas S,Kinetz E,Compton DL,Rojas E,Park JS,et al. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivoCellYear: 1996855015128653786|
|4.||Cohen MW,Godfrey EW. Early appearance of and neuronal contribution to agrin-like molecules at embryonic frog nerve-muscle synapses formed in cultureJ NeurosciYear: 199212298229921322981|
|5.||McMahan UJ. The agrin hypothesisCold Spring Harb Symp Quant BiolYear: 1990554074181966767|
|6.||Reist NE,Werle MJ,McMahan UJ. Agrin released by motor neurons induces the aggregation of acetylcholine receptors at neuromuscular junctionsNeuronYear: 19928865868|
|7.||Glass DJ,Bowen DC,Stitt TN,Radziejewski C,Bruno J,Ryan TE,Gies DR,Shah S,Mattsson K,Burden SJ,et al. Agrin acts via a MuSK receptor complexCellYear: 199685513523|
|8.||Gautam M,Noakes PG,Moscoso L,Rupp F,Scheller RH,Merlie JP,Sanes JR. Defective neuromuscular synaptogenesis in agrin-deficient mutant miceCellYear: 1996855255358653788|
|9.||Kim N,Stiegler AL,Cameron TO,Hallock PT,Gomez AM,Huang JH,Hubbard SR,Dustin ML,Burden SJ. Lrp4 is a receptor for Agrin and forms a complex with MuSKCellYear: 2008135334342|
|10.||Zhang B,Luo S,Wang Q,Suzuki T,Xiong WC,Mei L. LRP4 serves as a coreceptor of agrinNeuronYear: 200860285297|
|11.||Weatherbee SD,Anderson KV,Niswander LA. LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junctionDevelopment (Cambridge, England)Year: 200613349935000|
|12.||Jones G,Moore C,Hashemolhosseini S,Brenner HR. Constitutively active MuSK is clustered in the absence of agrin and induces ectopic postsynaptic-like membranes in skeletal muscle fibersJ NeurosciYear: 19991933763383|
|13.||Fuhrer C,Sugiyama JE,Taylor RG,Hall ZW. Association of muscle-specific kinase MuSK with the acetylcholine receptor in mammalian muscleEMBO JYear: 199716495149609305637|
|14.||Herbst R,Burden SJ. The juxtamembrane region of MuSK has a critical role in agrin-mediated signalingEMBO JYear: 200019677710619845|
|15.||Zhou H,Glass DJ,Yancopoulos GD,Sanes JR. Distinct domains of MuSK mediate its abilities to induce and to associate with postsynaptic specializationsJ Cell BiolYear: 19991461133114610477765|
|16.||Zhu D,Yang Z,Luo Z,Luo S,Xiong WC,Mei L. Muscle-specific receptor tyrosine kinase endocytosis in acetylcholine receptor clustering in response to agrinJ NeurosciYear: 2008281688169618272689|
|17.||Zhang Y,Moheban DB,Conway BR,Bhattacharyya A,Segal RA. Cell surface Trk receptors mediate NGF-induced survival while internalized receptors regulate NGF-induced differentiationJ NeurosciYear: 2000205671567810908605|
|18.||Vieira AV,Lamaze C,Schmid SL. Control of EGF receptor signaling by clathrin-mediated endocytosisScienceYear: 1996274208620898953040|
|19.||Burke P,Schooler K,Wiley HS. Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular traffickingMol Biol CellYear: 2001121897191011408594|
|20.||McCann CM,Bareyre FM,Lichtman JW,Sanes JR. Peptide tags for labeling membrane proteins in live cells with multiple fluorophoresBiotechniquesYear: 20053894595216018556|
|21.||Doherty GJ,McMahon HT. Mechanisms of endocytosisAnnu Rev BiochemYear: 20097885790219317650|
|22.||Le Roy C,Wrana JL. Clathrin-and non-clathrin-mediated endocytic regulation of cell signallingNat Rev Mol Cell BiolYear: 2005611212615687999|
|23.||Gordon LR,Gribble KD,Syrett CM,Granato M. Initiation of synapse formation by Wnt-induced MuSK endocytosisDevelopment (Cambridge, England)Year: 201213910231033|
|24.||Donaldson JG. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membraneJ Biol ChemYear: 2003278415734157612912991|
|25.||Mukherjee S,Gurevich VV,Jones JC,Casanova JE,Frank SR,Maizels ET,Bader MF,Kahn RA,Palczewski K,Aktories K,et al. The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitizationProc Natl Acad Sci USAYear: 2000975901590610811902|
|26.||Caumont AS,Galas MC,Vitale N,Aunis D,Bader MF. Regulated exocytosis in chromaffin cells. Translocation of ARF6 stimulates a plasma membrane-associated phospholipase DJ Biol ChemYear: 1998273137313799430671|
|27.||Kahn RA,Randazzo P,Serafini T,Weiss O,Rulka C,Clark J,Amherdt M,Roller P,Orci L,Rothman JE. The amino terminus of ADP-ribosylation factor (ARF) is a critical determinant of ARF activities and is a potent and specific inhibitor of protein transportJ Biol ChemYear: 199226713039130461618801|
|28.||Naslavsky N,Weigert R,Donaldson JG. Convergence of non-clathrin-and clathrin-derived endosomes involves Arf6 inactivation and changes in phosphoinositidesMol Biol CellYear: 20031441743112589044|
|29.||Radhakrishna H,Donaldson JG. ADP-ribosylation factor 6 regulates a novel plasma membrane recycling pathwayJ Cell BiolYear: 199713949619314528|
|30.||Radhakrishna H,Klausner RD,Donaldson JG. Aluminum fluoride stimulates surface protrusions in cells overexpressing the ARF6 GTPaseJ Cell BiolYear: 19961349359478769418|
|31.||Sternweis PC,Gilman AG. Aluminum: a requirement for activation of the regulatory component of adenylate cyclase by fluorideProc Natl Acad Sci USAYear: 198279488848916289322|
|32.||Bergamin E,Hallock PT,Burden SJ,Hubbard SR. The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerizationMol CellYear: 20103910010920603078|
|33.||Okada K,Inoue A,Okada M,Murata Y,Kakuta S,Jigami T,Kubo S,Shiraishi H,Eguchi K,Motomura M,et al. The muscle protein Dok-7 is essential for neuromuscular synaptogenesisScienceYear: 20063121802180516794080|
|34.||Orth JD,McNiven MA. Get off my back! Rapid receptor internalization through circular dorsal rufflesCancer ResYear: 200666110941109617145849|
|35.||Orth JD,Krueger EW,Weller SG,McNiven MA. A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalizationCancer ResYear: 2006663603361016585185|
|36.||Sigismund S,Woelk T,Puri C,Maspero E,Tacchetti C,Transidico P,Di Fiore PP,Polo S. Clathrin-independent endocytosis of ubiquitinated cargosProc Natl Acad Sci USAYear: 20051022760276515701692|
|37.||Donaldson JG,Porat-Shliom N,Cohen LA. Clathrin-independent endocytosis: a unique platform for cell signaling and PM remodelingCell SignalYear: 2009211618647649|
|38.||Donaldson JG,Williams DB. Intracellular assembly and trafficking of MHC class I moleculesTrafficYear: 2009101745175219761542|
|39.||Naslavsky N,Weigert R,Donaldson JG. Characterization of a nonclathrin endocytic pathway: membrane cargo and lipid requirementsMol Biol CellYear: 2004153542355215146059|
|40.||Honda A,Nogami M,Yokozeki T,Yamazaki M,Nakamura H,Watanabe H,Kawamoto K,Nakayama K,Morris AJ,Frohman MA,et al. Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formationCellYear: 19999952153210589680|
|41.||Brown FD,Rozelle AL,Yin HL,Balla T,Donaldson JG. Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane trafficJ Cell BiolYear: 20011541007101711535619|
|42.||D’Souza-Schorey C,Chavrier P. ARF proteins: roles in membrane traffic and beyondNat Rev Mol Cell BiolYear: 2006734735816633337|
|43.||Zhang B,Liang C,Bates R,Yin Y,Xiong WC,Mei L. Wnt proteins regulate acetylcholine receptor clustering in muscle cellsMol BrainYear: 20125722309736|
|44.||Romanelli RJ,Wood TL. Directing traffic in neural cells: determinants of receptor tyrosine kinase localization and cellular responsesJ NeurochemYear: 20081052055206818248622|
|45.||Sadowski L,Pilecka I,Miaczynska M. Signaling from endosomes: location makes a differenceExp Cell ResYear: 20093151601160918930045|
|46.||Woller B,Luiskandl S,Popovic M,Prieler BE,Ikonge G,Mutzl M,Rehmann H,Herbst R. Rin-like, a novel regulator of endocytosis, acts as guanine nucleotide exchange factor for Rab5a and Rab22Biochim Biophys ActaYear: 201118131198121021419809|
|47.||Kunze M,Neuberger G,Maurer-Stroh S,Ma J,Eck T,Braverman N,Schmid JA,Eisenhaber F,Berger J. Structural requirements for interaction of peroxisomal targeting signal 2 and its receptor PEX7J Biol ChemYear: 2011286450484506222057399|
|48.||Nizhynska V,Neumueller R,Herbst R. Phosphoinositide 3-kinase acts through RAC and Cdc42 during agrin-induced acetylcholine receptor clusteringDev NeurobiolYear: 2007671047105817565704|
|EGF||epidermal growth factor|
|FACS||fluorescence-activated cell sorting|
|RTK||receptor tyrosine kinase|
Additional supporting information may be found in the online version of this article at the publisher’s web site:
Doc. S1. Supplementary materials and methods.
Fig. S1. MuSK turnover in COS-7 cells and C2 myotubes.
Fig. S2. MuSK colocalization with clathrin and lipid raft markers and transferrin internalization in the presence of clathrin and dynamin inhibitors.
Fig. S3. Rab11 regulates MuSK recycling.
Fig. S4. MuSK endocytosis involves the actin cytoskeleton and Arf6.
Fig. S5. The MuSK internalization is not altered upon cytochalasin D treatment or the expression of Arf6.
Fig. S6. MuSK activation by Dok7 and its colocalization with pTyr, Arf6 and endosomal markers.
Fig. S7. Agrin-induced AChR clustering is not affected in Myr-Arf1 treated myotubes.
Click here for additional data file (febs0280-3281-sd1.zip)
Keywords: Arf6, clathrin-independent endocytosis, endocytosis, MuSK, receptor tyrosine kinase.
Previous Document: Functional characterization of an ACCase subunit from the diatom Phaeodactylum tricornutum expressed...
Next Document: Human endometrial endothelial cells generate distinct inflammatory and antiviral responses to the TL...